Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Fu... (ong IP position and proprietary platform...)

HOME >> MEDICINE >> TECHNOLOGY

Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests

Date:12/11/2008

ong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company's first test, miRview(TM) squamous, is now commercially available through its Philadelphia-based CLIA-certified lab.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease and the timing of introduction of additional microRNA-based diagnostic tests, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services, all of which are in early stages of development; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
5. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
6. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
7. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
8. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
9. Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
10. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
11. Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics miRview(TM) Squamous Assay

Post Your Comments:

(Date:3/10/2010)... , March 10 CVS Caremark Corporation (NYSE: CVS ) today announced that its Board of Directors has approved a quarterly ... April 23, 2010 . , ... , , ... ... ...

(Date:3/10/2010)... ... ... ... ... ...

(Date:3/10/2010)... , ... ... ... , ... ...

[0] CVS Caremark Corporation Announces Quarterly Dividend [0] CareFusion Launches New Pyxis ProcedureStation(TM) Radio Frequency Identification System at Association of Perioperative Registered Nurses 57th Annual Congress [0] U.S. Surgeon General Dr. Regina M. Benjamin to Deliver Commencement Address at Albany College of Pharmacy and Health Sciences

... in,bioavailability versus standard oral Vitamin B12 tablet and ... 30 minutes, - Public Conference Call to ... -, CEDAR KNOLLS, N.J., July 28 ... new human clinical data,demonstrating a new, more bioavailable ...

... -, CHICAGO, July 28 Lack of ... groups in Alzheimer,s,disease clinical trials might reduce the ... according to new research reported today at the,2008 ... in Chicago., Alzheimer clinical trials seek to ...

Other Medicine Technology:Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation 2 Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation 3 Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation 4 Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 2 Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 3 Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 4 Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 5

Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials

(Date:3/10/2010)... the University of Wisconsin-Madison for the 16th annual symposium on emotion ... to disease and treatment. , ... Madison, WI (Vocus) ... of Wisconsin-Madison for the 16th annual symposium on emotion in April ... and treatment., , , , ,The brain is a very plastic ...

(Date:3/10/2010)... screening in groundbreaking publication, , ... ... released its first ever Annual Report on Prostate Diseases, which ... cancer, benign prostatic hyperplasia (BPH), erectile dysfunction, prostatitis, and related ... of talented prostate disease specialists contributed to the publication., , ...

(Date:3/10/2010)... at Johns Hopkins Medical Institutions, the Karolinska University Hospital and ... substance called Eprotirome in patients with high cholesterol. , ... ... -- An experimental thyroid drug reduces cholesterol without the troublesome ... a study published today in The New England Journal of ...

(Date:3/10/2010)... tests have conclusively demonstrated that BIOSECUR Lab, ... effective against the most prevalent and deadly ... the U.S. Food and Drug Administration’s (FDA’s) ... demonstrated that BIOSECUR antimicrobial product kills more ... and E. coli, just 15- to 30-seconds ...

(Date:3/10/2010)... mysteries of neurological and motor disease, , , WEDNESDAY, March ... the relationship between tobacco smoke and Parkinson,s disease, researchers ... risk for the disease but smoking a large number ... risk. , Previous research had suggested that smokers have ... finding, however, comes with a caveat. , "Given ...

Breaking Medicine News(10 mins):Health News:UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain, 2 Health News:UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain, 3 Health News:Harvard Medical School releases 2010 Annual Report on Prostate Diseases, 2 Health News:Harvard Medical School releases 2010 Annual Report on Prostate Diseases, 3 Health News:Thyroid Hormone Analogue for Treating High Cholesterol 2 Health News:Thyroid Hormone Analogue for Treating High Cholesterol 3 Health News:Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses 2 Health News:Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses 3 Health News:Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses 4 Health News:Longtime Smokers May Find Protection From Parkinson's 2

[0] UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain,[0] Harvard Medical School releases 2010 Annual Report on Prostate Diseases,[0] Thyroid Hormone Analogue for Treating High Cholesterol [0] Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses [0] Longtime Smokers May Find Protection From Parkinson's

... of Medicine and Public Health had found that children ... treatments might be treated with implantation of a vagus ... ,As an alternative to medication, the FDA had approved ... patients older than 12 to help control or reduce ...

... encourager the children to eat healthy. This is ... ,Researchers from Finland’s University of Turku had found ... habits among children with a family history of ... unhealthy behaviors are significant risk factors for heart ...

... inherited disease in which the oxygen-carrying protein in the ... a twisted (sickled) shape that can disrupt circulation, leading ... complications. // ,"Sickle cell anemia is a ... according to Dr.Ware, an expert in the field of ...

... Amphetamine, which are used as a Party drug ecstasy, ... University of Brimingham, in a new study have found ... Lymphoma. // ,John Gordon and his team from ... involved in mediating apoptosis in lymphoma cells. These anti-depressant ...

... developed a way to print DNA (Deoxyribonucleic Acid), which ... cheap as blood tests. ,The technique called Supramolecular ... are not generally used in medical diagnostics.// ... and his colleagues at the Massachusetts Institute of Technology ...

... Not, if latest research is to be believed. Venting ... very beneficial to health. ,Researchers at the ... there are interesting links between language content and health ... has health benefits. If people write out their feelings, ...

Other Medicine News:Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2 Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2

Children With Epilepsy Can Be Treated With Nerve Stimulation Family Counseling To Encourage Children Eat Healthy Initiation Of New Study To Help Children With Sickle Cell Anaemia Antidepressant Drug Found To Have Anti-Cancer Effects Genetic Tests Could Become As Affordable As Blood Tests Want To Be Healthy: Just Write!

... kits provide convenience and cost control. , ... trays offer a variety of wound dressing ... of the tracheostomized patient. , ,Tray ... trays with disposable inner cannula for both ...

... filled cuff conforms to the ... trachea. During mechanical ventilation the ... lowest possible cuff to tracheal ... the ventilatory cycle. This provides ...

Disposable tracheostomy care tray....

Medicine Products:

Economy Tracheostomy Care Tray Bivona® Fome-Cuf® Tracheostomy Tube Kits with SidePort™ AutoControl™ Airway Connector and CMD™355 TR Trach Care Tray 4691 TC Trach Care Tray

Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Fu...(ong IP position and proprietary platform...),Health